Fact CheckerSign in

NCT06877572Active, not recruiting

Weight Loss Management in Endometrial Cancer Survivors

Enacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
6 Mar 2025
Start date
25 Mar 2025
Primary completion date
Oct 2028
Lead sponsor
University of Kansas Medical Center
NCT number
NCT06877572

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 25 Mar 2025 to the primary completion date, Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently on a GLP-1 agonist
  • Currently on insulin

Other illness

  • Stroke, heart attack, end stage liver disease, or end stage kidney disease during the last 6 months.

Other

  • Unable to participate in behavior weight loss

Who the study is looking for

  • ≥18 years old
  • ECOG 0-2
  • BMI ≥ 30kg/m2
  • Completed surgical staging with no evidence of residual disease
  • Endometrioid endometrial adenocarcinoma, p53 wild type
  • Stage 1
  • Undergoing active surveillance +/- brachytherapy

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kansas Medical Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.